FRIDAY DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Reckitt Benckiser Group plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Reckitt and its senior executives developed a scheme to mislead both investors and the public about its Suboxone Film product, including health and safety risks. This scheme also facilitated the abuse of opiates by U.S. consumers. As part of the scheme, Reckitt touted the safety of the Suboxone Film product while falsely constructing safety concerns about traditional Suboxone tablets. Reckitt’s scheme enriched the company by more than
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Source: The Schall Law Firm